procaterol has been researched along with Pulmonary Disease, Chronic Obstructive in 11 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the effects of inhaled procaterol (Meptin Air : MA), a short-acting beta2-agonist, for proactive use rather than rescue use in dyspnea and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD), who complained of dyspnea in daily activities despite treatment with long-acting bronchodilators." | 9.14 | [Effect of proactive use of inhaled procaterol on dyspnea in daily activities and quality of life in patients with chronic obstructive pulmonary disease]. ( Endo, Y; Hasegawa, T; Iwashima, A; Nakayama, H; Satoh, H; Suzuki, E, 2009) |
| "To examine the effects of inhaled procaterol (Meptin Air : MA), a short-acting beta2-agonist, for proactive use rather than rescue use in dyspnea and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD), who complained of dyspnea in daily activities despite treatment with long-acting bronchodilators." | 5.14 | [Effect of proactive use of inhaled procaterol on dyspnea in daily activities and quality of life in patients with chronic obstructive pulmonary disease]. ( Endo, Y; Hasegawa, T; Iwashima, A; Nakayama, H; Satoh, H; Suzuki, E, 2009) |
| "Chronic obstructive pulmonary disease (COPD) is a progressive condition that classically causes dyspnea during physical activity." | 2.77 | Influence of inhaled procaterol on pulmonary rehabilitation in chronic obstructive pulmonary disease. ( Dobashi, K; Hasegawa, M; Horie, T; Shirakura, K; Wada, N, 2012) |
| "Fourteen patients with stable COPD who were referred to our clinic between July 2008 and October 2009 were evaluated in this study." | 2.76 | Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease. ( Homma, M; Kawagoshi, A; Morita, R; Sano, M; Satake, M; Sato, K; Shioya, T; Sugawara, K; Takahashi, H; Tamaki, A, 2011) |
| "Procaterol was inhaled three times a day at a dose of 20 pg, while oxitropium was inhaled three times a day at a dose of 200 microg." | 2.73 | Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities ( Honma, M; Sano, MA; Satake, M; Sato, K; Shioya, T; Sugawara, K; Takahashi, H, 2008) |
| "Fourteen patients with stable COPD (age: 72." | 1.51 | Combination of assist use of short-acting beta-2 agonists inhalation and guidance based on patient-specific restrictions in daily behavior: Impact on physical activity of Japanese patients with chronic obstructive pulmonary disease. ( Asami, M; Edakuni, N; Hamada, K; Hirano, T; Ichinose, M; Matsunaga, K; Ogawa, H; Oishi, K; Suetake, R; Uehara, S; Yamaji, Y, 2019) |
| "The pathogenesis of chronic obstructive pulmonary disease is related to fibrosis around the small airways." | 1.35 | Procaterol inhibits lung fibroblast migration. ( Desaki, M; Itakura, S; Kamitani, S; Kawasaki, S; Kohyama, T; Nagase, T; Takizawa, H; Yamauchi, Y, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Burioka, N | 1 |
| Nakamoto, S | 1 |
| Amisaki, T | 1 |
| Horie, T | 2 |
| Shimizu, E | 1 |
| Kodaka, N | 1 |
| Yamagishi, T | 1 |
| Watanabe, K | 1 |
| Kishimoto, K | 1 |
| Nakano, C | 1 |
| Oshio, T | 1 |
| Niitsuma, K | 1 |
| Shimada, N | 1 |
| Matsuse, H | 1 |
| Hirano, T | 1 |
| Matsunaga, K | 1 |
| Hamada, K | 1 |
| Uehara, S | 1 |
| Suetake, R | 1 |
| Yamaji, Y | 1 |
| Oishi, K | 1 |
| Asami, M | 1 |
| Edakuni, N | 1 |
| Ogawa, H | 1 |
| Ichinose, M | 1 |
| Tsujimura, Y | 1 |
| Hiramatsu, T | 1 |
| Kojima, E | 1 |
| Tabira, K | 1 |
| Kitaguchi, Y | 1 |
| Yasuo, M | 1 |
| Hanaoka, M | 1 |
| Ito, S | 1 |
| Uchida, A | 1 |
| Isobe, Y | 1 |
| Hasegawa, Y | 1 |
| Kohyama, T | 1 |
| Yamauchi, Y | 1 |
| Takizawa, H | 1 |
| Itakura, S | 1 |
| Kamitani, S | 1 |
| Desaki, M | 1 |
| Kawasaki, S | 1 |
| Nagase, T | 1 |
| Satoh, H | 1 |
| Iwashima, A | 1 |
| Endo, Y | 1 |
| Nakayama, H | 1 |
| Hasegawa, T | 1 |
| Suzuki, E | 1 |
| Satake, M | 2 |
| Takahashi, H | 2 |
| Sugawara, K | 2 |
| Kawagoshi, A | 1 |
| Tamaki, A | 1 |
| Homma, M | 1 |
| Morita, R | 1 |
| Sato, K | 2 |
| Sano, M | 1 |
| Shioya, T | 2 |
| Hasegawa, M | 1 |
| Dobashi, K | 1 |
| Wada, N | 1 |
| Shirakura, K | 1 |
| Sano, MA | 1 |
| Honma, M | 1 |
4 trials available for procaterol and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Effect of proactive use of inhaled procaterol on dyspnea in daily activities and quality of life in patients with chronic obstructive pulmonary disease].
Topics: Activities of Daily Living; Administration, Inhalation; Adrenergic beta-Agonists; Aged; Dyspnea; Fem | 2009 |
Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Ex | 2011 |
Influence of inhaled procaterol on pulmonary rehabilitation in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Exercise Therapy; Exercise Toleranc | 2012 |
Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities
Topics: Activities of Daily Living; Adrenergic beta-Agonists; Aged; Exercise; Exercise Test; Female; Forced | 2008 |
7 other studies available for procaterol and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
A Modified Method for Examining the Walking Pattern and Pace of COPD Patients in a 6-min Walk Test Before and After the Inhalation of Procaterol.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Bronchodilator Agents; Exercise Tolerance; Fema | 2017 |
Evaluation of Inhaled Procaterol for Potential Assist Use in Patients with Stable Chronic Obstructive Pulmonary Disease.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Female; Fo | 2018 |
Combination of assist use of short-acting beta-2 agonists inhalation and guidance based on patient-specific restrictions in daily behavior: Impact on physical activity of Japanese patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Asian People; Dyspnea; Exerci | 2019 |
Effect of pulmonary rehabilitation with assistive use of short-acting β2 agonist in COPD patients using long-acting bronchodilators.
Topics: Adrenergic beta-2 Receptor Agonists; Combined Modality Therapy; Exercise; Exercise Therapy; Humans; | 2021 |
Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Airway Resistance; Asthma; Br | 2016 |
Responsiveness to bronchodilator procaterol in COPD as assessed by forced oscillation technique.
Topics: Adult; Aged; Aged, 80 and over; Airway Resistance; Analysis of Variance; Bronchodilator Agents; Fema | 2017 |
Procaterol inhibits lung fibroblast migration.
Topics: Cell Migration Inhibition; Cells, Cultured; Fibroblasts; Fibrosis; Humans; Inflammation Mediators; L | 2009 |